Where do Taysha Gene Therapies, Inc.'s ratios come from?

Every ratio is computed from Taysha Gene Therapies, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.

	TTM Q1 '26	TTM Q4 '25	TTM Q3 '25	TTM Q2 '25	TTM Q1 '25
Profitability
Operating margin	-1,774.4%-549pp	-1,130.6%-33.1pp	-1,618.5%-733pp	-1,160.8%-554pp	-1,225.8%-659pp
Net margin	-1,738.4%—	-1,115.3%—	-1,583.7%—	——	——
EBITDA margin	-1,759.7%-550pp	-1,119.6%-36.8pp	-1,601.3%-729pp	-1,146.2%-549pp	-1,209.3%-653pp
Free cash flow margin	-1,503.6%-340pp	-960.1%+19.2pp	-1,349.6%-549pp	-1,019.2%—	-1,163.6%—
Returns
Return on equity	-97.3%—	-68.5%—	-64.9%—	——	——
Return on assets	-59.2%—	-43.3%—	-40.2%—	——	——
Efficiency
Asset turnover	0×0.0×	0×0.0×	0×0.0×	0×-0.1×	0×-0.1×
Liquidity
Current ratio	14×+8.7×	12.2×+6.8×	10.5×+5.0×	12.5×+7.3×	5.4×+2.0×
Quick ratio	14×+8.7×	12.2×+6.8×	10.5×+5.0×	12.5×+7.3×	5.4×+2.0×
Cash ratio	13.8×+8.6×	12×+6.7×	10.4×+5.0×	12.3×+7.3×	5.2×+2.0×
Leverage
Debt-to-equity	0.3×-0.8×	0.3×-0.6×	0.3×-0.4×	0.2×—	1.1×—
Debt-to-assets	0.2×-0.2×	0.2×-0.2×	0.2×-0.1×	0.2×-0.1×	0.4×0.0×
Interest coverage	-2,501.2×-1,539×	-1,753.9×-857×	-1,399×-1,288×	-1,146.4×-1,112×	-962.5×-941×
Per Share
Book value per share	$0.58+183%	$0.77+170%	$0.62+87.0%	$0.83+78.5%	$0.20-12.2%
Valuation
Market capitalization	$1.28B+351%	$1.51B+325%	$892.04M+119%	$619.83M+36.5%	$284.95M-50.7%
Enterprise value	$1.08B+368%	$1.26B+350%	$663.78M+112%	$366.83M+8.0%	$229.99M-55.4%
Price / sales	171.9×+132×	154.2×+112×	141.4×+100×	76.5×+41.3×	39.4×-1.4×
Price / book	6.1×+0.9×	6.1×+1.1×	4.1×-0.5×	2.5×—	5.2×—
EV / sales	144×+112×	128.6×+95.1×	105.2×+73.6×	45.3×+18.9×	31.8×-4.6×
Free cash flow yield	-8.7%+20.8pp	-6.2%+16.8pp	-9.5%+9.9pp	-13.3%—	-29.5%—
Earnings yield	-10.1%—	-7.2%—	-11.2%—	——	——

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

Where do Taysha Gene Therapies, Inc.'s ratios come from?: Every ratio is computed from Taysha Gene Therapies, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.